RegCell is a biotechnology company focused on developing an innovative epigenetic regulatory T-cell reprogramming platform. Originally founded in Japan, the company aims to advance its first-in-class therapies into clinical trials by 2025, with a strategic shift to the U.S. to enhance clinical development, global partnerships, and commercialization opportunities.
Leadership & Board
Current Number of Employees7
Current LinkedIn Followers979
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$54M
Total Amount Raised$54M
Total Funding Rounds2
Total Funding Rounds2
Latest Funding Amount$9M
Latest Funding Amount$9M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
RegCell had 7 employees as of April 27, 2026. The number of employees increased by 0 (0.00%) week-over-week.
7Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
RegCell had 979 followers as of April 27, 2026. The number of followers increased by 1 (0.10%) week-over-week.
979Latest Followers Count
1(0.10%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.